Prasad Narayan, Meyyappan Jeyakumar, Dhanorkar Manoj, Kushwaha Ravi, Mandal Kausik, Veeranki Vamsidhar, Behera Manas, Patel Manas, Yadav Brijesh, Bhadauria Dharmendra, Kaul Anupama, Yaccha Monika, Bhatt Mansi, Agarwal Vinita, Jain Monoj
Department of Nephrology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
Department of Medical Genetics, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
Clin Kidney J. 2024 Jul 23;17(8):sfae218. doi: 10.1093/ckj/sfae218. eCollection 2024 Aug.
Idiopathic nephrotic syndrome (NS) in children poses treatment challenges, with a subset developing steroid-resistant nephrotic syndrome (SRNS). Genetic factors play a role, yet data on paediatric SRNS genetics in India are scarce. We conducted a prospective study using whole-exome sequencing to explore genetic variants and their clinical correlations.
A single-centre prospective study (October 2018-April 2023) enrolled children with SRNS, undergoing renal biopsy and genetic testing per institutional protocol. Clinical, histological, and genetic data were recorded. DNA isolation and next-generation sequencing were conducted for genetic analysis. Data collection included demographics, clinical parameters, and kidney biopsy findings. Syndromic features were evaluated, with second-line immunosuppressive therapy administered. Patient and renal outcomes are presented for patients with and without genetic variants.
A total of 680 paediatric NS patients were analysed, with 121 (17.8%) having SRNS and 96 consent to genetic analysis. 69 (71.9%) had early SRNS, 27 (28.1%) late. Among participants, 62 (64.58%) had reportable genetic variants. The most common were in COL4A genes, with 20 (31.7%) positive. Renal biopsy showed focal segmental glomerulosclerosis in 31/42 (74%) with variants, 16/28 (57.1%) without variants. Second-line immunosuppressions varied, with CNIs the most common. Outcomes varied, with partial or complete remission achieved in some while others progressed to ESRD.
The study underscores the importance of genetic analysis in paediatric SRNS, revealing variants in 65.7% of cases. COL4A variants were predominant. Variants correlated with varied renal outcomes, highlighting potential prognostic implications. These findings emphasize the value of personalized approaches and further research in managing paediatric SRNS.
儿童特发性肾病综合征(NS)带来了治疗挑战,其中一部分会发展为激素抵抗性肾病综合征(SRNS)。遗传因素起一定作用,但印度关于儿童SRNS遗传学的数据稀缺。我们开展了一项前瞻性研究,采用全外显子组测序来探索基因变异及其临床相关性。
一项单中心前瞻性研究(2018年10月至2023年4月)纳入了SRNS患儿,按照机构方案进行肾活检和基因检测。记录临床、组织学和基因数据。进行DNA分离和二代测序以进行基因分析。数据收集包括人口统计学、临床参数和肾活检结果。评估综合征特征,并给予二线免疫抑制治疗。呈现了有和没有基因变异患者的患者及肾脏结局。
共分析了680例儿科NS患者,其中121例(17.8%)患有SRNS,96例同意进行基因分析。69例(71.9%)为早期SRNS,27例(28.1%)为晚期。在参与者中,62例(64.58%)有可报告的基因变异。最常见的是在COL4A基因中,20例(31.7%)呈阳性。肾活检显示,有变异的42例中有31例(74%)为局灶节段性肾小球硬化,无变异的28例中有16例(57.1%)为局灶节段性肾小球硬化。二线免疫抑制治疗各不相同,钙调神经磷酸酶抑制剂最为常见。结局各不相同,一些患者实现了部分或完全缓解,而另一些患者进展为终末期肾病。
该研究强调了基因分析在儿科SRNS中的重要性,揭示了65.7%的病例存在变异。COL4A变异占主导。变异与不同的肾脏结局相关,突出了潜在的预后意义。这些发现强调了个性化方法以及在管理儿科SRNS方面进一步研究的价值。